Zobrazeno 1 - 10
of 375
pro vyhledávání: '"Jesse A. Berlin"'
Autor:
David S Liebeskind, Sanket S Dhruva, Art Sedrakyan, Bruce Campbell, Gregory Pappas, Joseph Drozda, Danica Marinac-Dabic, Murray Sheldon, Jesse A Berlin, Jim Hu, Michael E Matheny, Kristi Mitchell, Benjamin Fisher, Jack L Cronenwett, Adam W Beck, Jens Eldrup-Jorgensen, Frederic S Resnic, Suvekshya Aryal, Philip Goodney, Timothy Feeney, Vincent Devlin, Elizabeth W Paxton, Courtney E Baird, Ralph Brindis, Kevin Baskin, Terrie Cowley, Jeffery Levy, Benjamin K Poulose, Charles R Rardin, James Tcheng, Charles Viviano
Publikováno v:
BMJ Surgery, Interventions, & Health Technologies, Vol 4, Iss Suppl 1 (2022)
Externí odkaz:
https://doaj.org/article/fdef8ab2d3d74e61ad8be7f00dd4423b
Autor:
Zachary J. Madewell, Natalie E. Dean, Jesse A. Berlin, Paul M. Coplan, Kourtney J. Davis, Claudio J. Struchiner, M. Elizabeth Halloran
Publikováno v:
Epidemics, Vol 37, Iss , Pp 100506- (2021)
Outbreaks of emerging pathogens pose unique methodological and practical challenges for the design, implementation, and evaluation of vaccine efficacy trials. Lessons learned from COVID-19 highlight the need for innovative and flexible study design a
Externí odkaz:
https://doaj.org/article/80f260e888874317973de4d54abe8f09
Autor:
Jonathan A. Cook, Steven A. Julious, William Sones, Lisa V. Hampson, Catherine Hewitt, Jesse A. Berlin, Deborah Ashby, Richard Emsley, Dean A. Fergusson, Stephen J. Walters, Edward C. F. Wilson, Graeme Maclennan, Nigel Stallard, Joanne C. Rothwell, Martin Bland, Louise Brown, Craig R. Ramsay, Andrew Cook, David Armstrong, Doug Altman, Luke D. Vale
Publikováno v:
Trials, Vol 19, Iss 1, Pp 1-8 (2018)
Abstract Background A key step in the design of a RCT is the estimation of the number of participants needed in the study. The most common approach is to specify a target difference between the treatments for the primary outcome and then calculate th
Externí odkaz:
https://doaj.org/article/93ca295eced54b009edc65547cf7cb8e
Autor:
William Sones, Steven A. Julious, Joanne C. Rothwell, Craig Robert Ramsay, Lisa V. Hampson, Richard Emsley, Stephen J. Walters, Catherine Hewitt, Martin Bland, Dean A. Fergusson, Jesse A. Berlin, Doug Altman, Luke David Vale, Jonathan Alistair Cook
Publikováno v:
Trials, Vol 19, Iss 1, Pp 1-11 (2018)
Abstract Background A key step in the design of a randomised controlled trial is the estimation of the number of participants needed. The most common approach is to specify a target difference in the primary outcome between the randomised groups and
Externí odkaz:
https://doaj.org/article/786357260d4a4d0fb61b7c490178b14b
Autor:
Sean Hennessy, Jesse A Berlin
Publikováno v:
American Journal of Epidemiology. 192:1-5
There is a compelling need to evaluate the real-world health effects of medical products outside of tightly controlled preapproval clinical trials. This is done through pharmacoepidemiology, which is the study of the health effects of medical product
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::907ba828ea88b68154616c4a64456c23
https://doi.org/10.1093/aje/kwac172
https://doi.org/10.1093/aje/kwac172
Autor:
Jonathan A. Cook, Steven A. Julious, William Sones, Joanne C. Rothwell, Craig R. Ramsay, Lisa V. Hampson, Richard Emsley, Stephen J. Walters, Catherine Hewitt, Martin Bland, Dean A. Fergusson, Jesse A. Berlin, Doug Altman, Luke D. Vale
Publikováno v:
Trials, Vol 18, Iss 1, Pp 1-7 (2017)
Abstract Background A key step in the design of a randomised controlled trial (RCT) is the estimation of the number of participants needed. By far the most common approach is to specify a target difference and then estimate the corresponding sample s
Externí odkaz:
https://doaj.org/article/194e122a087d464fa438367cb1911b4b
Autor:
Jonathan A Cook, Steven A Julious, William Sones, Lisa V Hampson, Catherine Hewitt, Jesse A Berlin, Deborah Ashby, Richard Emsley, Dean A Fergusson, Stephen J Walters, Edward CF Wilson, Graeme MacLennan, Nigel Stallard, Joanne C Rothwell, Martin Bland, Louise Brown, Craig R Ramsay, Andrew Cook, David Armstrong, Douglas Altman, Luke D Vale
Publikováno v:
Health Technology Assessment, Vol 23, Iss 60 (2019)
Background: The randomised controlled trial is widely considered to be the gold standard study for comparing the effectiveness of health interventions. Central to its design is a calculation of the number of participants needed (the sample size) for
Externí odkaz:
https://doaj.org/article/cba0e59595b74186aa0898150edfed89
Autor:
Ian J. Saldanha, Christopher H. Schmid, Joseph Lau, Kay Dickersin, Jesse A. Berlin, Jens Jap, Bryant T. Smith, Simona Carini, Wiley Chan, Berry De Bruijn, Byron C. Wallace, Susan M. Hutfless, Ida Sim, M. Hassan Murad, Sandra A. Walsh, Elizabeth J. Whamond, Tianjing Li
Publikováno v:
Systematic Reviews, Vol 5, Iss 1, Pp 1-11 (2016)
Abstract Background Data abstraction, a critical systematic review step, is time-consuming and prone to errors. Current standards for approaches to data abstraction rest on a weak evidence base. We developed the Data Abstraction Assistant (DAA), a no
Externí odkaz:
https://doaj.org/article/3b73b29a64e8480db248cf2deb722103
Publikováno v:
Pharmacoepidemiology
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7250cb34d35f1583cc0b14e5cce00022
https://doi.org/10.1002/9781119701101.ch20
https://doi.org/10.1002/9781119701101.ch20
Autor:
Kourtney Davis, John D. Seeger, Almut G. Winterstein, Barry J. Gertz, Jie Li, Nancy C. Santanello, Wei Zhou, Ching-Yu Wang, Nancy A Dreyer, Jesse A. Berlin
Publikováno v:
Clinical Pharmacology & Therapeutics. 111:187-199
Increased interest in real-world evidence (RWE) for clinical and regulatory decision making and the need to evaluate long-term benefits and risks of pharmaceutical products raise the importance of understanding the use of external controls (ECs) for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7025fe15637a43e52479d50b7544c217
https://doi.org/10.1002/cpt.2346
https://doi.org/10.1002/cpt.2346